OFI Advisors’s Novartis NVS Stock Holding History

OFI Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$217K	Sell	2,634 -33	-1%	-$2.94K	0.01%	1167
2015 Q2	$235K	Buy	2,667 +148	+6%	+$13.6K	0.01%	1169
2015 Q1	$223K	Buy	2,519 +87	+4%	+$7.72K	0.01%	1189
2014 Q4	$202K	Sell	2,432 -20	-0.8%	-$1.66K	0.01%	1202
2014 Q3	$207K	Sell	2,452 -213	-8%	-$17.2K	0.01%	1126
2014 Q2	$216K	Sell	2,665 -219	-8%	-$17.2K	0.02%	1116
2014 Q1	$220K	Sell	2,884 -111	-4%	-$8.09K	0.02%	1054
2013 Q4	$216K	Hold	2,995	–	–	0.02%	1041
2013 Q3	$206K	Sell	2,995 -381	-11%	-$25.2K	0.02%	955
2013 Q2	$214K	Buy	+3,376	New	+$220K	0.02%	842

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

OFI Advisors's NVS Position: Q3 2015 in Review

OFI Advisors reduced its Novartis (NVS) stake by 1.2% in Q3 2015, selling an estimated $2.94K and leaving 2,634 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #1167.

OFI Advisors first reported a position in NVS in Q2 2013 and has held it in 10 quarters since. The position peaked at $235K in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

OFI Advisors held 2,634 shares of Novartis worth $217K as of Q3 2015.
OFI Advisors sold 33 Novartis shares in Q3 2015, an estimated $2.94K.
Novartis made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1167 holding.
OFI Advisors first reported a position in Novartis in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Novartis position peaked at $235K in Q2 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.